OnKure Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2022 to Q1 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary: OnKure Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2022 to Q1 2024.
OnKure Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $96K, a 32.4% decline year-over-year.
OnKure Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $500K, unchanged from 2022.

Operating Lease, Payments, Trailing 12 Months (USD)

Operating Lease, Payments, Quarterly (USD)

Operating Lease, Payments, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024		$96K	-$46K	-32.4%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q1 2023	$511K	$142K	+$11K	+8.4%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	$500K	$169K			Oct 1, 2022	Dec 31, 2022	10-K	2024-03-28
Q3 2022		$100K			Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-08
Q2 2022		$100K			Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-09
Q1 2022		$131K			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.